The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 495.20
Bid: 494.80
Ask: 495.20
Change: -4.40 (-0.88%)
Spread: 0.40 (0.081%)
Open: 497.80
High: 499.80
Low: 494.80
Prev. Close: 499.60
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Standard Life Assurance Acquisition

31 Aug 2018 17:45

RNS Number : 4552Z
Phoenix Group Holdings
31 August 2018
 

-NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

 

Completion of acquisition of Standard Life Assurance

Phoenix Group Holdings ("Phoenix" or the "Company") is pleased to announce the completion of the acquisition of Standard Life Assurance from Standard Life Aberdeen plc (the "Acquisition").

 

CEO of Phoenix, Clive Bannister, said: "I am delighted that we have completed the acquisition of Standard Life Assurance and I would like to extend a warm welcome to our new colleagues joining Phoenix. This deal will result in Phoenix becoming Europe's largest consolidator of heritage life funds, and the ongoing Strategic Partnership with Standard Life Aberdeen plc will provide additional growth opportunities. This strategically and financially compelling transaction supports our vision to be Europe's Leading Life Consolidator."

 

The Company is also pleased to announce that, with effect from Completion, Barry O'Dwyer and Campbell Fleming, both nominated by Standard Life Aberdeen plc, have been appointed non-executive directors of the Company. There are no additional disclosures required in respect of these appointments under paragraph 9.6.13R of the Listing Rules, save for those made in the Company's previous announcement of 25 June 2018 (RNS number: 3200S).

 

As the Acquisition constitutes a reverse takeover under the Listing Rules, admission of the Company's ordinary shares to the premium listing segment of the Official List and to trading on the LSE's main market for listed securities will be cancelled at 8.00 a.m. on 3 September 2018. Applications have been made to the UKLA and the LSE for (i) admission of the 144,114,450 ordinary shares issued to Standard Life Aberdeen plc as part consideration for the Acquisition and (ii) re-admission of the Company's existing 577,036,477 ordinary shares, to the premium listing segment of the Official List of the UKLA and to trading on the LSE's main market for listed securities ("Re-admission"). It is expected that Re-admission will become effective at 8.00 a.m. on 3 September 2018.

 

Capitalised terms used in this announcement have the meanings set out in the Circular and Prospectus or the Supplementary Prospectus, which are available on Phoenix's website at www.thephoenixgroup.com. 

 

Enquiries

Investors/Analysts:

 

PhoenixClaire Hawkins, Head of Investor Relations+44 (0)20 3735 0575

 

HSBC (Sponsor)

Graeme Lewis, Simon Alexander, Richard Fagan

+44 (0)20 7991 8888

 

Media:

 

MaitlandAndy Donald, Vikki Kosmalska+44 (0)20 7379 5151

 

Phoenix

Shellie Wells, Head of Corporate Communications

+44 (0)20 3735 0922 / +44 (0)7872 414137

 

Important Notices

This announcement has been issued by and is the sole responsibility of the Company. This announcement is not a circular or a prospectus but an advertisement.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for any securities in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities will be made in the United States, Australia, Canada, Japan or South Africa or any other jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in, and should not be distributed, forwarded to or transmitted in or into, the United States, Australia, Canada, Japan, South Africa or any other jurisdiction where to do so might constitute a violation of local securities laws or regulations.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Circular and Prospectus and the Supplementary Prospectus should not be distributed, forwarded to or transmitted in or into the United States, Australia, Canada, Japan, South Africa or any other restricted or excluded territories or any jurisdiction where to do so would be unlawful.

HSBC Bank plc, which is authorised by the Prudential Regulatory Authority ("PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority ("FCA"), is acting exclusively for the Company and for no one else in connection with the arrangements described in the Circular and Prospectus and the Supplementary Prospectus and will not regard any other person as a client in relation to the arrangements described in the Circular and Prospectus and the Supplementary Prospectus and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the arrangements referred to in the Circular and Prospectus and the Supplementary Prospectus.

No person has been authorised to give any information or to make any representations other than those contained in the Circular and Prospectus and the Supplementary Prospectus and, if given or made, such information or representations must not be relied on as having been authorised by the Company or HSBC. Subject to the Listing Rules, the Prospectus Rules and the Disclosure Guidance and Transparency Rules of the FCA, the issue of this announcement shall not, under any circumstances, create any implication that there has been no change in the affairs of the Company since the date of this announcement or that the information in it is correct as at any subsequent date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBXGDIISXBGIB
Date   Source Headline
22nd Jun 20214:40 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
16th Jun 20213:00 pmRNSBlock Listing Application
15th Jun 202112:00 pmRNSDiscussions in Respect of Sale Discontinued
9th Jun 20218:30 amRNSDirector/PDMR Shareholding
28th May 20212:00 pmRNSTotal Voting Rights
20th May 20214:00 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSStatement in Response to Press Speculation
17th May 20216:15 pmRNSHolding(s) in Company
14th May 20212:15 pmRNSResult of AGM
13th May 20219:00 amRNSDirector/PDMR Shareholding
30th Apr 202111:45 amRNSTotal Voting Rights
13th Apr 20211:00 pmRNSDirector/PDMR Shareholding
7th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 202112:00 pmRNSDirector/PDMR Shareholding
31st Mar 20212:00 pmRNSTotal Voting Rights
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
29th Mar 20214:40 pmRNSNotice of AGM
24th Mar 20214:15 pmRNSDirector/PDMR Shareholding
19th Mar 202111:30 amRNSDirector/PDMR Shareholding
18th Mar 202110:00 amRNSHolding(s) in Company
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20214:30 pmRNSDirector/PDMR Shareholding
8th Mar 20213:15 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNS2020 Annual Financial Results
26th Feb 20212:00 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPhoenix and SLA simplify Strategic Partnership
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
8th Feb 20216:00 pmRNSDirector/PDMR Shareholding
29th Jan 20213:30 pmRNSTotal Voting Rights
21st Jan 20214:45 pmRNSHolding(s) in Company
8th Jan 20213:10 pmRNSDirector/PDMR Shareholding
31st Dec 202011:00 amRNSTotal Voting Rights
29th Dec 202010:45 amRNSHolding(s) in Company
24th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20203:30 pmRNSBlock listing Return
11th Dec 20202:45 pmRNSDirector/PDMR Shareholding
9th Dec 20204:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSPhoenix Group Holdings plc - Trading Update
30th Nov 20204:00 pmRNSTotal Voting Rights
24th Nov 20207:00 amRNSStatement Regarding Press Speculation
6th Nov 20205:30 pmRNSDirector/PDMR Shareholding
6th Nov 20204:15 pmRNSDirector/PDMR Shareholding
30th Oct 202012:30 pmRNSTotal Voting Rights
28th Oct 20205:30 pmRNSDirector/PDMR Shareholding
28th Oct 202010:30 amRNSNotice of Delisting of Restricted Tier 1 Notes
27th Oct 20202:48 pmRNSNotice of Variation and Relisting of Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.